• Home
• Reimbursement Services Overview
  • Benefits Investigation
  • Appeals Assistance
  • Patient Assistance
• ERBITUX® (cetuximab)
• SPRYCEL® (dasatinib)
• IXEMPRA® (ixabepilone)
• Resources
• Sign Up for Updates
• Contact Us
•  

Reimbursement Services Overview

Destination Access Provides:

• Benefits Investigation
• Appeals Assistance
  • Appeals for Physicians and Patients
  • Pretreatment Appeals
  • Posttreatment Appeals
  • Medicare Part B Appeals Process
  • FAQs About Medicare Part B Appeals
  • Medicare Part D Appeals Process
  • FAQs About Medicare Part D Appeals
• Patient Assistance

 

 

 

 

Please see ERBITUX Important Safety Information and Full Prescribing Information including Boxed WARNINGS regarding infusion reactions and cardiopulmonary arrest.

Please see SPRYCEL Important Safety Information and full Prescribing Information.

Please see IXEMPRA Important Safety Information and full Prescribing Information, including boxed WARNING regarding hepatic impairment.

©2009 Bristol-Myers Squibb; All rights reserved.
ERBITUX is a registered trademark of ImClone LLC.
SPRYCEL is a registered trademark of Bristol-Myers Squibb.
IXEMPRA is a registered trademark of Bristol-Myers Squibb.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

693US09WA02301 03/09

 

1-800-861-0048
7:00 AM - 7:00 PM
CST (M-F)